Economics for everybody : Adopting a universal care pathway in rare disease by Meng Jiang

Meng Jiang is a PhD student from the Paris School of Economics and the university Paris 1 Panthéon-Sorbonne. She is a health economist who has background in Economics, Data Sciences, and Finance. Her past work has focused on improving equity and efficiency in rare diseases, using the methods from behavioural and experimental economics and economic theory. Her current studies will shed light on the construction of a generic care pathway, eliciting preferences on health information using experiments, and measuring R&D spillovers cross rare and non-rare drugs.
Her thesis is funded by the Institute of Genetic Diseases “Imagine” and is attached to the PSE doctoral programme “Enterprise and Society”.